H.C. Wainwright analyst Mitchell Kapoor lowered the firm’s price target on Carisma Therapeutics (CARM) to $5 from $8 and keeps a Buy rating on ...

The black, ankle-length faux fur coat from the self-proclaimed soft-goth label gave Graham a rockstar edge at the F1 event.

周一，H.C. Wainwright调整了对临床阶段生物制药公司Carisma Therapeutics Inc (NASDAQ: CARM)的财务展望。该公司分析师将公司股票的目标价从此前的$8.00下调至$5.00，同时维持买入评级。